Ariadne Genomics, Hadasit deal

Ariadne and Hadasit's BioMarCare Technologies Ltd. subsidiary partnered to co-develop a diagnostic to predict patient response to metastatic colorectal cancer treatment. BioMarCare will develop the diagnostic, while both companies will be responsible for clinical testing. The Binational Industrial Research and Development (BIRD) Foundation will provide a $900,000 grant to the partners for the project. Ariadne will have rights to commercialize the diagnostic in the U.S., while Hadasit will have rights in Europe and Israel. ...